Your trusted source for investing success

Tag: licensing agreement

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 

Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines

Tetraphase Pharmaceuticals (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that it has entered into an exclusive licensing agreement with Everest Medicines, a C-Bridge Capital-backed biopharmaceutical company based in China, to develop and commercialize eravacycline in mainland China, Taiwan,

What Is In-Licensing?

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions.

Fintech Stocks in Canada

Fintech Stocks in Canada

While the current state of the Canadian fintech market pales in comparison to the rest of the world, its uses and adoptions are expected to increase in the country. Here are nine fintech stocks in Canada.

NanoSphere Featured on CFN Media

NanoSphere Featured on CFN Media

NanoSphere Health Sciences (CSE:NSHS)  got featured in CFN Media for their recently developed innovative delivery technology that solves important issues around cannabinoid bioavailability.

“With an existing licensing agreement, the company is also well on its way to commercialization after spending more than a decade fine-tuning its technology–and developing products that have

3tl Technologies Signs Two Licensing Agreements

3tl Technologies (TSXV:TTM) has announced it has signed license agreements in January with two repeat clients–a brewing company and a pet food brand company.

As quoted in the press release:
This is the third time that the Brewing Company, which has annual revenues of approximately US$11 billion (See press release dated Aug. 3, 2017), has

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines

URL: https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/tetraphase-pharmaceuticals-enters-exclusive-development-commercialization-agreement-everest-medicines/